Omada Health, Inc. Income Statement
OMDA / Health Care|3 years of annual SEC 10-K data (FY2023-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 3 fiscal years. All figures from audited SEC 10-K filings.
Omada Health, Inc. reported $260M in revenue and $13M in net loss for FY2025. Revenue has grown at a 45.6% compound annual rate over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $260.2M | $169.8M | $122.8M |
| Cost of Revenue | $89.3M | $66.9M | $52.8M |
| Gross Profit | $170.9M | $102.9M | $70.0M |
| SG&A Expense | $52.2M | $42.6M | $36.0M |
| R&D Expense | $40.7M | $35.9M | $33.7M |
| Operating Income | -$12.0M | -$43.7M | -$66.0M |
| Income Tax | $0 | $0 | $0 |
| Net Income | -$12.8M | -$47.1M | -$67.5M |
| EPS (Basic) | -$9.52 | -$6.11 | -$9.52 |
| EPS (Diluted) | -$9.52 | -$6.11 | -$9.52 |
| Shares Outstanding | 8.2M | 7.7M | 7.1M |
| Gross Margin | 65.7% | 60.6% | 57.0% |
| Operating Margin | -4.6% | -25.7% | -53.8% |
| Profit Margin | -4.9% | -27.8% | -55.0% |